ArticleJournal of psychopathology and clinical science2025
Thinking beyond substances: Why behavioral "addiction" research must move past substance use disorder paradigms.
Article in Journal of psychopathology and clinical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Affect Regulation Motives for Gambling and Gambling Engagement: A Two-Year Random-Intercept Cross-Lagged Panel Model.International gambling studies · 2026Article
- Compulsive sexual behavior disorder (CSBD) and problematic pornography use (PPU): A comprehensive, interdisciplinary, and expert-informed narrative review with suggested future directions.Journal of behavioral addictions · 2026Review
- Sexual and Clinical Profile in Spanish-Speaking Individuals with Problematic Engagement in Online Sexual Activities: Comparison Between Subclinical and Clinical Groups.Archives of sexual behavior · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
In this viewpoint article, the authors contend that behavioral addiction (BA) research must move past substance use disorder paradigms. Under the most liberal definitions of BA, activities such as eating, exercise, work, smartphone use, and a litany of others could all become addictions. Abundant clinical evidence shows that people may frequently engage in behaviors in ways that become impairing. Yet, frequency of engagement in a behavior is insufficient evidence that addiction is occurring and may be of little evidentiary value at all. There are also severe problems with assuming equivalence between all behavioral processes and substance use. The conceptual problems manifest in methodological problems, meaning that many of the methodological approaches used in substance use research are likely not valid for BA research. Given abundant evidence that the behavior patterns commonly referred to as BAs are associated with distress and impairment, BAs are likely to continue to garner interest in both clinical care and clinical science. To better understand the phenomenology of BAs, research should first start with systematic and multimethod investigations among patients reporting such problems. That is, rather than simply co-opting methods and measures from substance use disorder (SUD) research, BA research should carefully consider the signs and symptoms reported by people experiencing real impairments from excessive and dysregulated behavioral engagements. Additionally, BA researchers should seek to engage with larger theoretical perspectives on psychopathology regarding the core processes that seem to be driving such impairments. For BA research to achieve scientific legitimacy, explain clinical phenomena, and, ultimately, reduce human suffering, the study of such disorders must move beyond SUD paradigms and addiction framing alone and instead strive for riskier tests of validity. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.